Sintilimab, sold under the brand Tyvyt among others, is a medication used to treat Hodgkin's disease, and has been approved in China
This report contains market size and forecasts of Sintilimab in global, including the following market information:
Global Sintilimab Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Sintilimab Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Sintilimab companies in 2021 (%)
The global Sintilimab market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
10 ml Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Sintilimab include Innovent and Eli Lilly and Company etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Sintilimab manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Sintilimab Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Sintilimab Market Segment Percentages, by Type, 2021 (%)
10 ml
Others
Global Sintilimab Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Sintilimab Market Segment Percentages, by Application, 2021 (%)
Adult
Senior Person
Children
Global Sintilimab Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Sintilimab Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Sintilimab revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Sintilimab revenues share in global market, 2021 (%)
Key companies Sintilimab sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Sintilimab sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Innovent
Eli Lilly and Company